Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Argonaut Therapeutics logo — Argonaut Therapeutics uses PRMT5 inhibitors and companion di...

Argonaut Therapeutics

Argonaut Therapeutics uses PRMT5 inhibitors and companion diagnostics for precision cancer treatment based on Oxford research.

Founded 2016 11-50 employees Corporate Round Total: $2.57M Health Care, Health and Wellness

General Information

Company Name Argonaut Therapeutics
Founded Year 2016
Founders / Decision Makers
Team member
Employees 11-50
Industries Health Care, Health and Wellness
Funding Stage Corporate Round
Social

BounceWatch is an independent company data service, not affiliated with Argonaut Therapeutics. To contact Argonaut Therapeutics, visit argonauttherapeutics.co.uk.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Argonaut Therapeutics compare?

A PDF of Argonaut Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Argonaut Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Argonaut Therapeutics

Argonaut Therapeutics is a health care startup founded in 2016, which has received a significant $2.57M corporate round investment from JW Pharmaceuticals on 29 October 2018. The company, a spin-out of Oxford University's Medical Sciences Division, is dedicated to leveraging PRMT5 inhibitors and companion diagnostics for precision cancer treatment, building upon original research findings from Oxford. Their focus lies in identifying abnormal arginine methylation in advanced and metastatic tumors and establishing PRMT5 as a therapeutic target. Through the development of two unique series of PRMT5 inhibitors and proprietary companion diagnostics, Argonaut Therapeutics aims to deliver tailored and precise therapy for individual cancer patients.

Business keywords: Precision therapeutics, Cancer treatment, PRMT5 inhibitors, Companion diagnostics, Oxford University, Medical research, Epigenetics, Precision medicine, Cancer therapy, Research spin-out, Clinical trials, Drug development, Metastatic tumors, Enzyme targeting

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Corporate Round $2.57M 1
JW Pharmaceuticals
29 Oct 2018
Seed Round Undisclosed 1
Oxford Science Enterprises
Oxford Science Enterprises
01 Oct 2016

Argonaut Therapeutics Alternatives & Competitors

View All Alternatives
Argonaut Therapeutics vs
Phoenix Molecular Designs
Phoenix Molecular Designs United States

A clinical stage biopharmaceutical company designing precise cancer therapeutics to address unmet me...

Series A
22 employees
Biotechnology, Health Care
Argonaut Therapeutics vs
SOLID Therapeutics
SOLID Therapeutics Denmark

An early-stage oncology company aiming to treat solid tumors

5 employees
Argonaut Therapeutics vs
Cascadian Therapeutics, Inc.
Cascadian Therapeutics, Inc. United States

Cascadian Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in developin...

Post-IPO Equity
10 employees
Biotechnology, Health Care
View all alternatives

FAQ About Argonaut Therapeutics

Argonaut Therapeutics uses PRMT5 inhibitors and companion diagnostics for precision cancer treatment based on Oxford research.
Argonaut Therapeutics was founded in 2016.
Argonaut Therapeutics operates in Health Care and Health and Wellness. Its work centres on Precision therapeutics, Cancer treatment, PRMT5 inhibitors and Companion diagnostics.
Argonaut Therapeutics has approximately 11-50 employees.
Argonaut Therapeutics has completed 2 funding rounds, raising a total of $2.57M. The latest funding stage is Corporate Round.
Top alternatives and competitors to Argonaut Therapeutics include Phoenix Molecular Designs, SOLID Therapeutics, Cascadian Therapeutics, Inc., Quanta Therapeutics, ORIC Pharmaceuticals Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Argonaut Therapeutics and Phoenix Molecular Designs are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Argonaut Therapeutics, https://bouncewatch.com/company/argonaut-therapeutics, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout